珍视明（江西）药业股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
59
NMPA:59
Drug Approvals
Sodium Hyaluronate Eye Drops
- Product Name
- 玻璃酸钠滴眼液
- Approval Number
- 国药准字H20258087
- Approval Date
- May 23, 2025
NMPA
Diquafosol Sodium Eye Drops
- Product Name
- 地夸磷索钠滴眼液
- Approval Number
- 国药准字H20244250
- Approval Date
- Jun 28, 2024
NMPA
Timolol Maleate Eye Drops
- Product Name
- 马来酸噻吗洛尔滴眼液
- Approval Number
- 国药准字H20093749
- Approval Date
- Dec 21, 2023
NMPA
Dextran 70 and Glycerol Eye Drops
- Product Name
- 右旋糖酐70甘油滴眼液
- Approval Number
- 国药准字H20184022
- Approval Date
- Dec 17, 2023
NMPA
Dextran 70 and Glycerol Eye Drops
- Product Name
- 右旋糖酐70甘油滴眼液
- Approval Number
- 国药准字H20093798
- Approval Date
- Dec 17, 2023
NMPA
Azelastine Hydrochloride Eye Drops
- Product Name
- 盐酸氮䓬斯汀滴眼液
- Approval Number
- 国药准字H20090032
- Approval Date
- May 30, 2023
NMPA
Tobramycin & Dexamethasone Eye Drops
- Product Name
- 妥布霉素地塞米松滴眼液
- Approval Number
- 国药准字H20083299
- Approval Date
- Sep 30, 2022
NMPA
Compound Allantoin VitaminB6-E and Aminoethylsulfonic Acid Eye Drops
- Product Name
- 复方尿维氨滴眼液
- Approval Number
- 国药准字H20083276
- Approval Date
- Sep 30, 2022
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- Next
Clinical Trials
No trials found
News
No news found